News
Aitua Ltd Portfolio Company enters into agreement with European medical device company, Vygon
6 February 2008
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that one of its portfolio companies, Probe Scientific (“Probe”) has entered into an agreement with Vygon, one of Europe’s leading medical device companies and a major supplier to the intensive care market, to co-develop Probe’s revolutionary blood sampling device, MicroEye®, alongside Vygon’s IV access devices.
Aitua Ltd Portfolio Company Innova Establishes Worldwide Distributor Network
13 December 2007
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that one of its portfolio companies, Innova Biosciences Limited (“Innova”), has just completed its seventh distributor agreement in the last two months.
Probe Scientific strengthens Board with new appointment
6 December 2007
Probe Scientific has strengthened its board by the appointment of George Zajicek as a non executive director.
Aitua Ltd Portfolio Company Probe Scientific Launches its MicroEye® Device and Gains First Export Order
13 November 2007
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that one of its portfolio companies, Probe Scientific (“Probe”), the medical device company, has formally launched its revolutionary MicroEye® device and has already secured its first export order.
Aitua invests in ViraBiotech’s instant flu protection
4 October 2007
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that it has invested £50,000 in ViraBiotech Limited (“ViraBiotech”), a company focused on the commercialisation of groundbreaking research by Professor Nigel Dimmock at the University of Warwick which provides a totally new approach to combating flu viruses.
Aitua invests in Lightning-Link™ company Innova
12 June 2007
The life science IP commercialisation company Aitua Limited (“Aitua”) is pleased to announce that it has invested £100,000 into Innova BioSciences Limited (“Innova").
Aitua Ltd Portfolio Company Probe Scientific Gains EU approval for its MicroEye® Device
1 June 2007
Single-use blood sampling device eliminates needle puncture in blood sampling.
Aitua launched on Babraham Research Campus
2 April 2007
Aitua Limited the life science IP commercialisation company was launched today as the new brand for Babraham BioConcepts.
Aitua invests in Specialty Ophthalmic Company Altacor
20 March 2007
Aitua Limited is delighted to announce that it has invested in Altacor Limited, a new specialty pharmaceutical company in the area of therapeutic ophthalmology.
Innova's latest product slashes research processing time
19 February 2007
Innova Biosciences Limited announces the launch of the latest exciting new addition to its revolutionary conjugation technology suite, Lightning-Link™.
CTM Biotech Acquisition to Boost Growth for Alpha Biologics
19 February 2007
Babraham BioConcepts Limited is pleased to announce the sale of portfolio company CTM Biotech to Alpha Biologics Sdn Bdh of Malaysia. The transaction marks BioConcepts’ first exit since its launch in October 2006.
Rainbow Seed Fund backs BioConcepts
18 December 2006
Babraham BioConcepts Limited is today pleased to announce that it has closed additional funding from the Rainbow Seed Fund.
New pictures of Probe Scientific’s MicroEye™
1 October 2006
These pictures show examples of the first production devices. These have been rigorously tested and meet all the required quality checks.